These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 7693839)

  • 1. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
    Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
    J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro.
    Belenky SN; Robbins RA; Rubinstein I
    J Leukoc Biol; 1993 May; 53(5):498-503. PubMed ID: 7684763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
    Wanikiat P; Woodward DF; Armstrong RA
    Br J Pharmacol; 1997 Nov; 122(6):1135-45. PubMed ID: 9401778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide synthase inhibitor and lipopolysaccharide effects on reactivity of guinea pig airways.
    Fedan JS; Warner TE; Yuan LX; Robinson Va; Frazer DG
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1141-50. PubMed ID: 7534351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.
    Finkel MS; Oddis CV; Mayer OH; Hattler BG; Simmons RL
    J Pharmacol Exp Ther; 1995 Feb; 272(2):945-52. PubMed ID: 7531767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting of nitric oxide synthase inhibitors to system y+ in activated macrophages.
    Baydoun AR; Mann GE
    Biochem Biophys Res Commun; 1994 Apr; 200(2):726-31. PubMed ID: 7513994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
    Reif DW; McCreedy SA
    Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase.
    Robertson CA; Green BG; Niedzwiecki L; Harrison RK; Grant SK
    Biochem Biophys Res Commun; 1993 Dec; 197(2):523-8. PubMed ID: 7505570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of chemotaxis Ng-monomethyl-L-arginine: a role for cyclic GMP.
    Kaplan SS; Billiar T; Curran RD; Zdziarski UE; Simmons RL; Basford RE
    Blood; 1989 Nov; 74(6):1885-7. PubMed ID: 2553158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms.
    Chen LY; Mehta JL
    J Pharmacol Exp Ther; 1996 Jan; 276(1):253-7. PubMed ID: 8558439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.
    Schmidt K; Klatt P; Mayer B
    Mol Pharmacol; 1993 Sep; 44(3):615-21. PubMed ID: 7690451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic guanosine monophosphate is the mediator of platelet-activating factor inhibition on transport by the mouse kidney thick ascending limb.
    Néant F; Imbert-Teboul M; Bailly C
    J Clin Invest; 1994 Sep; 94(3):1156-62. PubMed ID: 7521885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nitric oxide on chemotaxis and endotoxin-induced interleukin-8 production in human neutrophils.
    Corriveau CC; Madara PJ; Van Dervort AL; Tropea MM; Wesley RA; Danner RL
    J Infect Dis; 1998 Jan; 177(1):116-26. PubMed ID: 9419178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antinociceptive activity of Muntingia calabura aqueous extract and the involvement of L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in its observed activity in mice.
    Zakaria ZA; Sulaiman MR; Jais AM; Somchit MN; Jayaraman KV; Balakhrisnan G; Abdullah FC
    Fundam Clin Pharmacol; 2006 Aug; 20(4):365-72. PubMed ID: 16867020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response.
    Craven PA; Studer RK; DeRubertis FR
    J Clin Invest; 1994 Jan; 93(1):311-20. PubMed ID: 7506712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysmorphogenic effects of nitric oxide (NO) and NO-synthase inhibition: studies with intra-amniotic injections of sodium nitroprusside and NG-monomethyl-L-arginine.
    Lee QP; Juchau MR
    Teratology; 1994 Jun; 49(6):452-64. PubMed ID: 7538231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of endogenous nitric oxide synthase inhibitors and endothelin-1 for regulating myometrial contractions during gestation in the rat.
    Momohara Y; Sakamoto S; Obayashi S; Aso T; Goto M; Azuma H
    Mol Hum Reprod; 2004 Jul; 10(7):505-12. PubMed ID: 15155819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide stimulates cyclic guanosine monophosphate production and electrogenic secretion in Caco-2 colonocytes.
    Rolfe VE; Milla PJ
    Clin Sci (Lond); 1999 Feb; 96(2):165-70. PubMed ID: 9918896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of various agonists on nitric oxide generation by human polymorphonuclear leukocytes.
    Stolarek R; Kula P; Kurmanowska Z; Nowak D
    Int J Clin Lab Res; 1998; 28(2):104-9. PubMed ID: 9689552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.